J Pediatr Infect Dis 2024; 19(06): 339-344
DOI: 10.1055/s-0044-1791802
Original Article

Evaluation of a Risk Model for Sepsis Early Prediction in Infants with Epidermolysis Bullosa

Shuyan Zhang
1   Department of Pediatrics, Affiliated Hospital of Hebei Engineering University, Handan, China
,
Jing Wang
2   Department of Internal Medicine-Neurology, Affiliated Hospital of Hebei Engineering University, Handan, China
,
Lingyu Li
3   Department of Dermatology, Affiliated Hospital of Hebei Engineering University, Handan, China
,
Liyan Jiao
3   Department of Dermatology, Affiliated Hospital of Hebei Engineering University, Handan, China
,
Xiaojuan Liu
3   Department of Dermatology, Affiliated Hospital of Hebei Engineering University, Handan, China
,
Lili Ping
4   Department of Neonatology, Handan Central Hospital, Handan, China
› Author Affiliations
Funding Application of clinical nursing pathway in infants with epidermolysis bullosa (20200208).

Abstract

Objective Epidermolysis bullosa (EB) is a severe hereditary condition characterized by fragile skin that can lead to complications, including severe infections such as sepsis. Current research on sepsis in children with EB is limited, and there is a need for specific biomarkers that can aid in early detection and management.

Methods This study analyzed blood samples from 92 children diagnosed with EB, 42 of whom developed sepsis. We investigated various inflammatory proteins and clinical parameters as potential biomarkers. Multivariate analysis was used to determine predictors of sepsis occurrence.

Results Elevated levels of C-reactive protein (CRP), interleukin-6 (IL-6), lactate, and decreased oxygen saturation were significantly associated with sepsis in children with EB. The predictive model displayed an area under the receiver operating characteristic curve of 0.80 in the training set and 0.77 in the validation set, indicating good predictive accuracy.

Conclusion Our findings suggest that CRP, IL-6, lactate, and oxygen saturation are reliable predictors of sepsis in children with EB. These biomarkers should be monitored closely to facilitate early diagnosis and improve outcomes in this vulnerable population. The study underscores the need for tailored research and diagnostic strategies for children with EB at risk of sepsis.

Supplementary Material



Publication History

Received: 06 May 2024

Accepted: 18 September 2024

Article published online:
18 October 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Marchili MR, Spina G, Roversi M. et al. Epidermolysis Bullosa in children: the central role of the pediatrician. Orphanet J Rare Dis 2022; 17 (01) 147
  • 2 García-Espinosa L, Del Rosal T, Quintana L. et al. Bloodstream infection in children with epidermolysis bullosa. Pediatr Infect Dis J 2023; 42 (06) 510-514
  • 3 Williams FN, Lee JO. Pediatric burn infection. Surg Infect (Larchmt) 2021; 22 (01) 54-57
  • 4 Sheridan RL. Sepsis in pediatric burn patients. Pediatr Crit Care Med 2005; 6 (3, Suppl): S112-S119
  • 5 Rhodes A, Evans LE, Alhazzani W. et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43 (03) 304-377
  • 6 Ferrer R, Martin-Loeches I, Phillips G. et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42 (08) 1749-1755
  • 7 Kumar A, Roberts D, Wood KE. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34 (06) 1589-1596
  • 8 Zhang C, Shang X, Yuan Y, Li Y. Platelet–related parameters as potential biomarkers for the prognosis of sepsis. Exp Ther Med 2023; 25 (03) 133
  • 9 Pociute A, Kottilingal Farook MF, Dagys A, Kevalas R, Laucaityte G, Jankauskaite L. Platelet-derived biomarkers: potential role in early pediatric serious bacterial infection and sepsis diagnostics. J Clin Med 2022; 11 (21) 6475
  • 10 Pilar-Orive FJ, Astigarraga I, Azkargorta M, Elortza F, Garcia-Obregon S. A three-protein panel to support the diagnosis of sepsis in children. J Clin Med 2022; 11 (06) 1563
  • 11 Nour Z, El-Hamamsy K, Ehsan I. et al. MicroRNAs as potential diagnostic new biomarkers in diagnosis of sepsis in pediatric patients. Rep Biochem Mol Biol 2022; 11 (02) 327-335
  • 12 Goh KH, Wang L, Yeow AYK. et al. Artificial intelligence in sepsis early prediction and diagnosis using unstructured data in healthcare. Nat Commun 2021; 12 (01) 711
  • 13 Lanziotti VS, Póvoa P, Soares M, Silva JR, Barbosa AP, Salluh JI. Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva 2016; 28 (04) 472-482
  • 14 Wong HR. Pediatric sepsis biomarkers for prognostic and predictive enrichment. Pediatr Res 2022; 91 (02) 283-288
  • 15 Malluvalasa S, Arigela V, Lanka S. et al. Comparative study of procalcitonin versus C-reactive protein in the diagnosis of sepsis in children below 16 years-a single centre observational study. Int J Pediatr Reprod Sci 2017; 1: 85-89
  • 16 Tsaqilah L, Diana IA, Gondokaryono SP. et al. A retrospective study on the clinical, laboratory, and nutritional status of pediatric epidermolysis bullosa in a tertiary referral hospital in West Java, Indonesia. Clin Cosmet Investig Dermatol 2023; 16: 1615-1621
  • 17 Fuentes I, Yubero MJ, Morandé P. et al. Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients. Int Wound J 2023; 20 (03) 774-783
  • 18 Yıldırım R, Devecioğlu MC. IL-6, IL-8, TNF-α and C-reactive protein levels in the diagnosis and prognosis of neonatal sepsis. Van Tip Derg 2022; 29 (03) 297-302
  • 19 Shapiro NI, Howell MD, Talmor D. et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005; 45 (05) 524-528
  • 20 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
  • 21 Deng P, Tang N, Li L, Zou G, Xu Y, Liu Z. Diagnostic value of combined detection of IL-1β, IL-6, and TNF-α for sepsis-induced cardiomyopathy. Med Clin (Barc) 2022; 158 (09) 413-417
  • 22 Bender L, Thaarup J, Varming K, Krarup H, Ellermann-Eriksen S, Ebbesen F. Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull 2008; 55 (04) 219-223
  • 23 Savochkina AY, Poltorak A, Nikushkina KV, Zotova MA. Relationships between the indices of innate immunity in sepsis depend on clinical outcomes. Russ J Immunol 2022; 25 (03) 291-294
  • 24 Denstaedt SJ, Cano J, Wang XQ, Donnelly JP, Seelye S, Prescott HC. Blood count derangements after sepsis and association with post-hospital outcomes. Front Immunol 2023; 14: 1133351
  • 25 Bateman RM, Sharpe MD, Jagger JE. et al; S South Yorkshire Hospitals Research Collaboration. 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016. Crit Care 2016; 20 (Suppl. 02) 94 [published correction appears in Crit Care. 2016 Oct 24;20:347]
  • 26 Saunderson RB, Vekic DA, Mallitt K, Mahon C, Robertson SJ, Wargon O. A retrospective cohort study evaluating the accuracy of clinical diagnosis compared with immunofluorescence and electron microscopy in children with inherited epidermolysis bullosa. Br J Dermatol 2019; 180 (05) 1258-1259